Ignite Creation Date:
2024-05-06 @ 1:54 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04155580
Status:
TERMINATED
Last Update Posted:
2023-02-21
First Post:
2019-11-05
Brief Title:
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With RelapsedRefractory Acute Myeloid Leukemia AML
Sponsor:
Organization:
Astex Pharmaceuticals Inc